| normal controls | FPLD2 | FPLD3 | HIVPL | APL | CGL |
---|---|---|---|---|---|---|
number | 6 | 10 | 2 | 1 | 1 | 2 |
age (years) | 40 ± 16 | 48 ± 16 | 36 ± 15 | 41 | 64 | 40 ± 1 |
BMI (kg/m2) | 26.4 ± 6.73 | 24.3 ± 2.07 | 33.9 ± 0.72 | 28.3 | 20.3 | 23.0 ± 0.08 |
Molecular genetic basis of disease | None | LMNA R482Q (all) | PPARG F388L (all) | None | LMNB2 R215G | BSCL2 frameshift (both) |
diabetes | 0/6 | 3/10 | 1/2 | 0/1 | 1/1 | 2/2 |
hypertension | 1/6 | 5/10 | 2/2 | 1/1 | 1/1 | 1/1 |
dyslipidemia | 0/6 | 10/10 | 2/2 | 1/1 | 1/1 | 1/1 |
total cholesterol (mM) | 4.41 ± 0.54 | 4.76 ± 1.13 | 3.80 ± 0.43 | 5.37 | 3.63 | 4.08 ± 0.78 |
triglycerides (mM) | 1.08 ± 0.63 | 2.62 ± 1.09 | 1.84 ± 1.27 | 6.29 | 2.82 | 2.13 ± 0.83 |
LDL cholesterol (mM) | 2.36 ± 0.33 | 2.59 ± 1.11 | 2.42 ± 0.59 | ND | 1.50 | 2.09 ± 0.69 |
HDL cholesterol (mM) | 1.56 ± 0.45 | 1.01 ± 0.29 | 0.88 | 0.50 | 0.85 | 1.04 ± 0.44 |
fasting blood glucose (mM) | 4.71 ± 1.14 | 6.01 ± 1.74 | 8.35 ± 0.21 | 5.30 | 12.6 | 6.65 ± 1.34 |
insulin (uIU/mL) | 13.8 ± 13.7 | 19.0 ± 14.6 | 29.5 ± 14.9 | 27.8 | 63.6 | 140 ± 130 |
apolipoprotein B (g/L) | 0.71 ± 0.12 | 0.90 ± 0.18 | ND | ND | 0.75 | 0.99 ± 0.43 |
apolipoprotein A-I (g/L) | 1.51 ± 0.38 | 1.25 ± 0.28 | ND | ND | 1.06 | 1.04 ± 0.21 |
systolic blood pressure (mm/Hg) | 119 ± 19.2 | 127 ± 13.7 | 134 ± 8.49 | 126 | 108 | 113 ± 7 |
diastolic blood pressure (mm/Hg) | 70 ± 11.7 | 73.5 ± 8.9 | 71.0 ± 8.5 | 82 | 56.0 | 75.0 ± 7.1 |
waist circumference (cm) | 87.0 ± 19.2 | 87.5 ± 7.9 | 118 ± 17 | 107 | 118 | 77.5 ± 0.7 |